“Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor”, IJKD, vol. 18, no. 2, pp. 108–117, Jun. 2024, doi: 10.52547/es880614.